Peptides · Peptide comparison
Larazotide vs Thymosin Beta-4
Restore your intestinal barrier and protect against gluten damage
The body's natural healing peptide that accelerates tissue repair and reduces inflammation
- Healing & Recovery
- Healing & Recovery
At a glance
Quick comparison
Efficacy
Benefit ratings
Intestinal Barrier Protection
Celiac Disease Management
Safety & Tolerability
Wound Healing
Inflammation Reduction
Tissue Regeneration
Technical data
Compound specifications
Larazotide
- Molecular formula
- C34H59N9O12
- Molecular weight
- 785.9 g/mol
- Half-life
- Unknown - acts primarily as local intestinal barrier regulator rather than systemic drug
- Bioavailability
- Orally administered; acts locally on intestinal epithelium with minimal systemic absorption
- CAS number
- 206899-25-6
Thymosin Beta-4
- Molecular formula
- C212H350N56O78S
- Molecular weight
- 4963
- Half-life
- Dose-dependent (increases with higher doses)
- Bioavailability
- 100% (subcutaneous and intravenous)
- CAS number
- 77591-33-4
Protocols
Dosing compared
Larazotide
Oral
- 0.5 mgThree times daily (before meals) · 12 weeks in trials; ongoing for symptom controlTrial-established dose: in a Phase 2b randomized controlled trial in celiac disease, 0.5 mg three times daily met the primary endpoint with fewer symptoms vs placebo. Notably, the higher 1 mg and 2 mg doses showed no benefit over placebo, so 0.5 mg is the effective dose [6]. Taken before meals as a local intestinal tight-junction regulator [1].
Thymosin Beta-4
Subcutaneous injection
- 2-5 mg (community injectable practice for 'TB-500')Once or twice weekly · 4-6 week loading phase, then weekly maintenanceDocumented community/research-practice injectable dosing for tissue repair; thymosin beta-4 has ~100% bioavailability by the subcutaneous route [1]. Not an FDA-approved use.
Topical ophthalmic (eye drops)
- 0.1% (1 mg/mL) RGN-259 solution, 1 dropSeveral times daily (e.g. up to 5x/day) · 4 weeks0.1% RGN-259 ophthalmic solution used in phase III neurotrophic keratopathy and dry-eye trials, applied as eye drops several times daily for ~4 weeks [5].
Intravenous injection
- 450-1200 mgIV push daily for the first 3 days, then weekly · Total of 7 doses over ~5 weeksDoses studied in the RGN-352 acute myocardial infarction clinical program, given IV after PCI [6].
Applications
Best suited for
Larazotide
- Managing celiac disease symptoms despite strict gluten avoidance
- Larazotide is particularly well-suited for individuals focused on managing celiac disease symptoms despite strict gluten avoidance. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [6].
- Reducing accidental gluten exposure damage
- Larazotide is particularly well-suited for individuals focused on reducing accidental gluten exposure damage. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Restoring digestive comfort and nutrient absorption
- Larazotide is particularly well-suited for individuals focused on restoring digestive comfort and nutrient absorption. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Supporting intestinal healing and barrier function
- Larazotide is particularly well-suited for individuals focused on supporting intestinal healing and barrier function. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Thymosin Beta-4
- Post-Surgery Recovery
- Accelerates healing of surgical wounds and reduces post-operative inflammation and scarring
- Chronic Wound Management
- Helps pressure ulcers, venous stasis ulcers, and other slow-healing wounds progress faster
- Tissue Regeneration
- Supports repair of damaged tissues from injury, burns, or degenerative conditions
Safety profile
Side effects
Larazotide
Common
- Nausea
- Abdominal Cramping
- Fatigue
Uncommon
- Transient Diarrhea
Serious
- Allergic Reaction
Thymosin Beta-4
Common
- Injection site redness
- Injection site swelling
Uncommon
- Temporary mild headache
- Mild bruising at injection site
- Transient fatigue
Serious
- Allergic reaction
Research status
Safety & evidence
Larazotide
- Evidence level
- Strong human trials (Phase 3 or FDA approved)
- FDA status
- Not FDA approved
- Safety overview
- Larazotide (AT-1001) is a synthetic tight-junction regulator. In Phase 2 celiac disease trials it reduced symptoms at the 0.5 mg dose, but a pooled analysis found no improvement in intestinal permeability versus placebo; safety was comparable to placebo [1][6]. The mechanism—zonula occludens-1 modulation—is specific to epithelial tight junctions without broad immunosuppression. Gastrointestinal side effects (nausea, diarrhea, abdominal pain) occur in 10-20% of patients but are typically mild and resolve with dose adjustment or continued exposure. FDA feedback on Phase 3 trials indicated efficacy trends but required additional manufacturing and clinical data before approval consideration.
Contraindications
- Known hypersensitivity to larazotide or any component
- Severe gastrointestinal obstruction
- Active untreated infections (may require monitoring)
- Pregnancy and breastfeeding (limited safety data)
Thymosin Beta-4
- Evidence level
- Moderate human trials (Phase 1-2)
- FDA status
- Research compound
- Safety overview
- Thymosin Beta-4 is a naturally occurring peptide found in all cells and body fluids in the human body. Clinical trials have demonstrated excellent safety even at very high doses. IV studies showed doses up to 1260 mg were well tolerated with no serious adverse events.
Contraindications
- Active systemic infections
- Severe immunosuppression
- Hypersensitivity to thymosin or any component
- Pregnancy (insufficient safety data)
Decision guide
Which is right for you?
Larazotide
Choose Larazotide if…
- Managing celiac disease symptoms despite strict gluten avoidance
- Reducing accidental gluten exposure damage
- Restoring digestive comfort and nutrient absorption
- Supporting intestinal healing and barrier function
Thymosin Beta-4
Choose Thymosin Beta-4 if…
- Recovering from injuries or surgery
- Improving wound healing speed
- Reducing inflammation
- Minimizing scar formation